Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease

Patrocinadores de la web
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Meiji Pharma
Faes Farma
GP Pharm
ACCORD